Background: The purpose of this retrospective study was to report the results, after a minimum of 18.5 years of follow-up, in a consecutive series of total hip arthroplasties performed with an alumina-on-alumina combination.
Methods: One hundred and eighteen consecutive total hip arthroplasties were performed in 106 patients between 1979 and 1980. The prostheses combined a 32-mm alumina head and an all-alumina socket. Both components were cemented in eighty-five hips, both components were implanted without cement in twenty-nine, and only the stem was cemented in four. The mean age of the patients at the time of the index arthroplasty was 62.2 years (range, thirty-two to eighty-nine years).
Results: At the 18.5 to 20.5-year follow-up evaluation, forty-five patients (fifty-one hips) were alive and had not had a revision, twenty-five patients (twenty-five hips) had undergone revision of one or both components, twenty-seven patients (thirty hips) had died, and nine patients (twelve hips) had been lost to follow-up. The mean Merle d’Aubigné hip score (and standard deviation) was 16.2 ± 1.8 points at the latest follow-up evaluation. The rate of survival at twenty years, with revision for any reason as the end-point, was 85.6% for the cementless cups compared with 61.2% for the cemented cups and 84.9% for the cementless stems compared with 87.3% for the cemented stems. Wear of the prosthetic components was undetectable on plain radiographs. Periprosthetic cystic or scalloped lesions requiring the use of allograft bone during revision were present in three of the twenty-five revised hips. In addition, seven hips had moderate acetabular osteolysis treated with a 4-mm-larger cup. No fracture of the alumina socket or head was recorded. The mean acetabular wear rate in this series was <0.025 mm/yr.
Conclusion: With the alumina-on-alumina total hip arthroplasty, minimal wear rates and limited osteolysis can be expected up to twenty years after the operation, provided that sound acetabular component fixation is obtained.
Moussa Hamadouche, MD, PhD; Laboratoire de Recherches Orthopédiques, Faculté de Médicine Lariboisière St. Louis, Université D. Diderot Paris VII, UPRES A CNRS 7052, 10, avenue de Verdun, 75010 Paris, France. E-mail address for M. Hamadouche: email@example.com
Laurent Sedel, MD; Service de Chirurgie Orthopédique, Hôpital Lariboisière, 2, rue Ambroise Paré, F-75475 Paris CEDEX 10, France
Pierre Boutin, MD; Deceased
Jacques Daussange, MD; Clinique Marzet, 40 boulevard Alsace Lorraine, 64000 Pau, France
Mark E. Bolander, MD; Orthopaedic Research Laboratory, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905